Skip to main content
CRVL logo

CRVL · Corvel Corp · Financials

Track CRVL — free
$80.71 -0.60 (-0.74%) At close · Oct 21
Market Cap
$4.08B
Shares
50.52M
Volume · Oct 21 126.22K Avg daily vol (3M) 189.68K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$958.53M +7%
FY2026 Revenue FY2017–FY2026
Net Income
$110.34M +16%
FY2026 Net Income FY2010–FY2026
Gross Margin
24.29% +0.9pp
FY2026 Gross Margin FY2017–FY2026
Diluted EPS
$2.14 +16.9%
FY2026 Diluted EPS FY2010–FY2026
Operating Cash Flow
$155.64M +22.2%
FY2026 Operating Cash Flow FY2010–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
$983.74M $958.53M $895.59M $795.31M $718.56M $646.23M $552.64M $592.23M $595.74M $558.35M $518.69M — — — — — — —
$739.85M $725.66M $685.86M $623.62M $560.3M $494.12M $429.02M $466.3M $470.93M $451.1M $413.89M $399.04M $392.66M $370.34M $337.65M $318.83M $284.1M $252.43M
$243.9M $232.86M $209.73M $171.69M $158.26M $152.11M $123.62M $125.92M $124.81M $107.25M $104.79M $104.54M $99.97M $108.48M $91.66M $93.84M $96.57M $85.54M
— 24.29% 23.42% 21.59% 22.02% 23.54% 22.37% 21.26% 20.95% 19.21% 20.2% — — — — — — —
$92.71M $89.73M $88.9M $76.59M $73.71M $67.6M $64.45M $65.21M $63.3M $59.35M $57.24M $58.48M $54.41M $51.97M $47.77M $50.41M $59.17M $42.06M
— $175K $383K $423K $425K $435K $435K $435K $440K $437K $437K $450K $457K $470K $484K $584K — —
$32.94M $31.76M $29.54M $26.25M $25.12M $23.92M $23.44M $22.52M $22.98M $21.78M $20.95M $19.95M $18M $16.41M $15.74M $14.72M $12.25M $11.99M
$151.19M $143.13M $120.82M $95.1M $84.55M $84.51M $59.18M $60.71M $61.51M $47.9M $47.55M $46.06M $45.56M $56.51M $43.9M $43.44M $37.4M $43.48M
$35.86M $32.79M $25.66M $18.85M $18.19M $18.1M $12.82M $13.33M $14.81M $12.21M $18.07M $17.54M $16.97M $22.12M $17.17M $16.89M $12.74M $17.39M
$115.33M $110.34M $95.17M $76.25M $66.37M $66.41M $46.36M $47.38M $46.7M $35.7M $29.48M $28.53M $28.59M $34.39M $26.73M $26.55M $24.66M $26.1M
— 11.51% 10.63% 9.59% 9.24% 10.28% 8.39% 8% 7.84% 6.39% 5.68% — — — — — — —
USD/shares $2.25 $2.15 $1.85 $1.48 $1.28 $1.25 $0.86 $0.86 $0.83 $0.63 $0.51 $0.48 $0.46 $0.54 $0.40 $0.39 $0.70 $0.70
USD/shares $2.25 $2.14 $1.83 $1.47 $1.26 $1.22 $0.85 $0.85 $0.82 $0.62 $0.50 $0.48 $0.46 $0.54 $0.40 $0.38 $0.68 $0.69
shares — 51.28M 51.38M 51.37M 51.98M 53.26M 53.79M 54.98M 56.38M 56.48M 58.25M 59.48M 62.01M 63.31M 66.77M 68.86M 35.4M 37.5M
shares — 51.63M 51.99M 52.04M 52.78M 54.38M 54.5M 55.81M 57.02M 57.13M 58.71M 60.01M 62.67M 64.12M 67.37M 69.76M 36.09M 38.02M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2010–FY2026: $701.95M in buybacks.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Operating lease liabilities 2026-06-30 USD 28,394,000 10-Q filed 2026-08-06
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 7,607,000
Noncurrent operating lease liabilities
USD 20,787,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 4.49×
EV/EBIT
—
Peer median 24.76×
P/E (TTM)
35.87×
Peer median 31.18×

Peer medians compare against the 11 similar-size Insurance Brokers companies (of 25 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Patient Management Services $596,703,000 $581,192,000 $529,995,000 $478,751,000 $424,050,000 $368,853,000 $386,814,000 $368,198,000
Network Solutions Services $361,824,000 $314,397,000 $265,316,000 $239,811,000 $222,180,000 $183,791,000 $205,411,000 $227,542,000
Key facts CIK 874866 CUSIP 221006109 13F (30d) 37 filings 36 filers Visit website Investor relations